MCI Physicians

MCI provides advanced, comprehensive cancer care with a highly skilled team of professionals. This interdisciplinary team works hand-in-hand with University-based and private practice surgical oncologists, our member physicians and referring physicians to develop individualized treatment plans tailored to the unique needs of each cancer patient.

Our team of clinicians, clinician-scientists and researchers work in a collaborative environment where we battle cancer on all fronts, from the “bench to bedside,” with cancer research and treatment under one roof. Meet our team of oncologists. We are here for you.

Thaddeus A. Beeker, M.D.
Thomas W. Butler, M.D.
Daniel G. Cameron, M.D.
David Clarkson, M.D. 
Michael A. Finan, M.D.
Arthur E. Frankel, M.D.
Nathaniel L. Jones, M.D.
Moh’d Khushman, M.D.
Carol Wiseman Norden, M.D.
Elesyia D. Outlaw, M.D.
Sachin Pai, M.B.B.S., M.D.
Rodney P. Rocconi, M.D.
Jennifer Scalici, M.D.
Clayton A. Smith, M.D., Ph.D. 
William R. Taylor, M.D.
Weisi Yan, M.D., Ph.D.

 

Beeker square 2001.jpgThaddeus A. Beeker, M.D.
Stem Cell Transplant Program Director
Professor of Interdisciplinary Clinical Oncology

A graduate of Wake Forest University and East Carolina University School of Medicine, Dr. Tad Beeker has spent the past 22 years in the practice of hematology/oncology in Mobile. He also co-founded the Peripheral Blood Stem Cell Transplant Program at Providence Hospital, which provides specific treatment for certain blood cancers. His clinical interests are multiple myeloma and stem cell transplants. Dr. Beeker has been active in clinical trials and is principal investigator on multiple trials through the National Cancer Institute.

 

Butler square 2001.jpgThomas W. Butler, M.D.
Senior Staff Medical Oncologist
Associate Professor of Interdisciplinary Clinical Oncology

Prior to joining MCI with appointments as an associate professor in both internal medicine and the physician assistant study program, Dr. Thomas Butler held assistant professorships with several prestigious teaching institutions, including Texas Tech University School of Medicine, East Carolina University School of Medicine, and Vanderbilt University School of Medicine. Strongly committed to helping patients cope with chronic disease, he says, “All cancer patients must be treated as unique individuals with personal needs, goals, and spiritual beliefs.” Dr. Butler’s clinical focus is supportive care for cancer patients, which focuses on improving quality of life. He is a member of the American Society of Clinical Oncology, American Society of Hematology, and is a fellow in the American College of Physicians, and also serves on the Board of Directors for the Leukemia Lymphoma Society of Alabama.

 

Cameron square 2001.jpgDaniel G. Cameron, M.D.
Senior Staff Medical Oncologist
Associate Professor of Interdisciplinary Clinical Oncology

Dr. Daniel Cameron joined MCI after serving the city of Mobile and other surrounding counties of South Alabama as part of a respected medical oncology team. Prior to pursuing a career in medicine, Dr. Cameron worked as a mechanical design engineer for General Electric’s Aircraft Engine division, where he was awarded multiple patents for his design work. After a decade working as an engineer, Dr. Cameron entered the University of Cincinnati College of Medicine and completed his internship and residency at Jewish Hospital in Cincinnati. During his residency, he worked on several published retrospective clinical studies related to colorectal cancer and thrombophilia. With his broad experience in all hematology and oncology diseases Dr. Cameron looks forward to expanding his special interests in translational research and clinical focused activities in colon and breast cancers.

 

Clarkson square 2001.jpgDavid Clarkson, M.D.
Senior Staff Physician, Medical Oncology Service
Professor of Interdisciplinary Clinical Oncology

Dr. David Clarkson’s career along the Gulf Coast began in 1974, when he accepted a faculty position at the University of South Alabama’s department of internal medicine and hematology. Over the years, he has distinguished himself in private practice as one of the leading medical oncologists in the region. His primary focus has been in the areas of hematology and lymphomas. As Senior Staff Physician, Dr. Clarkson oversees the vast array of clinical medical oncology services offered at the Institute. He also has a keen interest in the development and design of electronic medical records software, and has been instrumental in developing a program that navigates large, complex patient databases in order to manage medical problems more easily. Several of Dr. Clarkson’s innovations are copyrighted.

 

Finan square 2001.jpgMichael A. Finan, M.D.
Abraham A. Mitchell Chair
Director, USA Mitchell Cancer Institute

Dr. Michael A. Finan joined MCI in 2005 after serving as chairman of the Cancer Committee at Ochsner Clinic Foundation in New Orleans. He was named interin director of MCI in 2014 and director in May 2015. Dr. Finan specializes in a variety of cancers affecting women including cervical, vaginal, endometrial, vulvar, fallopian tube and ovarian cancer, as well as gestational trophoblastic neoplasia. Dr. Finan was the first gynecologist in Mobile to perform robotic surgery with the DaVinci Robotic Surgery System, and is listed in the most recent Top Doctors directory issued by U.S. News and World Report

 

Frankel 100 web.jpgArthur E. Frankel, M.D.
Chief, Medical Oncology
Arlene and Mayer Mitchell Chair of Medical Oncology

Dr. Arthur E. Frankel led cancer research and clinical programs for three decades across the South. He joined MCI in 2017 from the University of Texas Southwestern Medical Center in Dallas, where he oversaw Phase 1 clinical trials. Frankel was executive director of the Cancer Research Institute at Scott & White Hospital / Texas A&M School of Medicine and has served at Wake Forest University, the Medical University of South Carolina, the Florida Hospital Cancer and Leukemia Research Center and Duke University. He is a co-inventor on 12 issued patents and has authored or co-authored more than 200 publications in peer-reviewed journals. His research interests include melanoma, for which he is nationally renowned.

 

Jones_ 200 _N01.jpgNathaniel Jones, M.D.
Gynecologic Oncologist
Assistant Professor of Interdisciplinary Clinical Oncology

Dr. Nate Jones received his medical degree from East Tennessee State University Quillen College of Medicine and completed his residency training in obstetrics and gynecology at Mountain Area Health Education Center in Asheville, N.C. Prior to joining MCI in 2017 he completed his fellowship training in gynecologic oncology at New York Presbyterian Hospitals, a combined program through Columbia University College of Physicians and Surgeons and Weill Cornell Medical College. Dr. Jones is a member of the Society of Gynecologic Oncologists, the American Society of Clinical Oncology, the American College of Obstetricians and Gynecologists, and the American Association of Gynecologic Laparoscopists. His research interests include genetic and molecular characterization of uterine and ovarian cancers.

 

khushman-small.jpg

Moh’d Khushman, M.D.
Staff Medical Oncologist
Assistant Professor of Interdisciplinary Clinical Oncology

Dr. Moh’d Khushman joined MCI in 2015 after completing a fellowship in hematology-oncology at the University of Miami Leonard Miller School of Medicine. He has developed a clinical interest in GI malignancies and neuroendocrine tumors. A native of Jordan, Dr. Khushman earned his medical degree from the University of Jordan in Amman and completed his residency in internal medicine at Henry Ford Hospital in Detroit, where he served as chief medical resident. Dr. Khushman says he strives to provide hope to patients and aims for a cure. “In my research, I find exploring Mother Nature’s secrets a fascinating and wonderful experience,” he said. He is a member of the American Society of Clinical Oncology, the European Society of Medical Oncology, the American Society of Hematology and the American Association for Cancer Research. Dr. Khushman is board certified in Medical Oncology, Hematology and Internal Medicine. 

 

Carol Wiseman Norden, M.D.
Staff Physician, Medical Oncology Service
Assistant Professor of Interdisciplinary Clinical Oncology

A native Mobilian, Dr. Carole Wisemen Norden joined MCI in 2012 as a clinical oncologist and Assistant Professor of Interdisciplinary Clinical Oncology. Prior to joining MCI, she served as a hematologist/oncologist with Coast Clinical Oncology in Biloxi, Mississippi. Dr. Norden received her medical training at the University of South Alabama College of Medicine and holds Board Certifications in Medical Oncology and Internal Medicine. As a native Mobilian, she is keenly aware of cancer rates in this area, and has a passion for survivorship issues as well as special interests in breast cancer, lung cancer and palliative care. Dr. Norden appreciates the opportunity to offer patients enrollment on clinical trials as a treatment option. "Caring for cancer patients is a privilege and gift," says Dr. Norden who is a member of the American Society of Clinical Oncology, the American Academy of Hospice and Palliative Medicine, and the Mississippi State Medical Society.

 

Elesyia Outlaw mug.jpgElesyia D. Outlaw, M.D.
Director, Women's Radiotherapy Program

Director, Brachytherapy Program
Staff Radiation Oncologist
Associate Professor of Interdisciplinary Clinical Oncology

Dr. Elesyia Outlaw joined MCI after serving as an attending radiation oncologist at Touro Infirmary and Tulane Cancer Center in New Orleans. She earned her medical degree from St. Louis University School of Medicine in 2002. She completed clinical research in breast cancer at M.D. Anderson Cancer Center in Houston, an internship in the Department of Internal Medicine at Presbyterian Hospital of Dallas, and a residency in radiation oncology at Siteman Cancer Center at Washington University in St. Louis. Her areas of interest include breast and gynecologic malignancies.

 

Pai square 200.jpgSachin Pai, M.B.B.S., M.D.
Staff Medical Oncologist

Program Leader, Developmental Therapeutics
Assistant Professor of Interdisciplinary Clinical Oncology

Dr. Sachin Pai joined MCI in 2017 as a staff medical oncologist and program leader in Developmental Therapeutics. He comes to MCI from Northwestern University in Chicago, where he completed an advance fellowship in early phase clinical trials at Northwestern Medicine Developmental Therapeutics Institute. He also earned a master’s degree in Clinical Investigation. His clinical interests include malignancies of the gastrointestinal tract, including pancreatic cancer. Pai earned an MBBS (Bachelor of Medicine, Bachelor of Surgery) at Kasturba Medical College in Mangalore, India. He completed a residency in internal medicine at Louisiana State University Health Science Center in Shreveport and a fellowship in medical oncology at Ochsner Clinic Foundation in New Orleans.

 

rocconi square 2001.jpgRodney P. Rocconi, M.D.
Chief, Gynecologic Oncology Service

Professor of Interdisciplinary Clinical Oncology

Dr. Rodney P. Rocconi joined MCI as a physician-scientist in the Gynecologic Oncology Service in 2007. He specializes in the management of cancers of the ovary, uterus, cervix and lower genital tract. As associate director for Clinical Research, Dr. Rocconi provides leadership and medical expertise to the clinical trials department, reviews and designs clinical research protocols, evaluates safety and efficacy data, analyzes and summarizes data for presentation to regulatory agencies, and provides strategic guidance on non-regulatory clinical trial plans. In 2016, he was chosen as one of 16 oncologists nationally for a leadership program of the American Society of Clinical Oncology, the world’s leading professional organization for physicians and oncology professionals caring for people with cancer.

 

Scalici_200_J01.jpgJennifer Scalici, M.D.
Gynecologic Oncologist, Physician Scientist
Associate Professor of Interdisciplinary Clinical Oncology

Dr. Jennifer Scalici received her medical degree from the University of Alabama School of Medicine, and completed an internship and residency at Northwestern University, McGaw Medical Center. While a fellow at the University of Virginia Health System, she served as primary investigator in a study involving advanced epithelial ovarian cancer at the University of Virginia Cancer Center. Dr. Scalici is a member of American Association of Cancer Research Associate Member, Society of Gynecologic Oncologists: Fellow in Training, and the American College of Obstetricians and Gynecologists: Jr. Fellow. She has a special research interest in ovarian cancer metastasis and platinum resistance, and has published papers and given numerous presentations on gynecologic oncology topics.

 

Smith square 2001.jpgClayton A. Smith, M.D., Ph.D.
Staff Radiation Oncologist
Assistant Professor of Interdisciplinary Clinical Oncology

Dr. Clayton Smith joined MCI in July 2016 after completing his residency at Vanderbilt University in Nashville, Tennessee. Dr. Smith earned his medical degree and a Ph.D. in neuroscience from Tulane University in New Orleans. He completed a transition year residency at The Methodist Hospital in Houston, Texas. Dr. Smith treats all types of cancers and a full spectrum of patients from children to adults, and he is eligible for board certification in Radiation Oncology from the American Board of Radiology.

 

Taylor square 2001.jpgWilliam R. Taylor, M.D.
Senior Staff Medical Oncologist, Medical Oncology Service
Associate Professor of Interdisciplinary Clinical Oncology

Dr. William Taylor joined MCI after many years in private practice, serving as medical director of the Baptist Breast Health Center in Montgomery. While in Montgomery, he also served as a clinical instructor and lecturer for the University of Alabama at Birmingham Internal Medicine Program. Dr. Taylor is a graduate of the UAB Medical School and fulfilled his fellowship in medical oncology at the Duke University Medical Center. With 25 years of involvement in the treatment of cancer, he has a keen interest in cancer cell biology, tumor microenvironment, and angiogenesis, and what biologically can be altered or understood to help better customize cancer treatment. At MCI, Dr. Taylor plans to continue in his efforts to “personalize” cancer treatment, bringing his experience and knowledge not only into a new clinical practice on the Gulf Coast, but to the research lab as well.

 

Yan square 200.jpgWeisi Yan, M.D., Ph.D.
Director, CyberKnife Program
Staff Radiation Oncologist
Assistant Professor of Interdisciplinary Clinical Oncology

Dr. Weisi Yan joined MCI in 2016 after holding faculty appointments at New York-Presbyterian Hospital and New York Hospital Queens. He also served as assistant professor of clinical radiology at the Weill Cornell Medical College of Cornell University. Dr. Yan earned his medical degree from China Medical University and a Ph.D. from Cornell, where he trained in pharmacology. He completed his residency at Montefiore Medical Center/Albert Einstein College of Medicine and NYP/Cornell Medical Center, where he served as chief resident in the Department of Radiation Oncology. He rotated at Memorial Sloan Kettering Cancer Center during his residency training. Dr. Yan’s specialties are head and neck cancers, lung cancer, lymphoma and GI cancers. He has extensive training in stereotactic radiation therapy and uses this experience to direct MCI’s CyberKnife program.

 

Email Newsletters

Connect With Us